Teleflex Incorporated

NYSE:TFX

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🔬 Clinical Trials

🏥 Hospitals & Clinics

💻 Telehealth

Location

United States

Market Cap

USD 5.23 B

Share Price

USD 118.31

Avg Daily Volume

974,314

Change (1 day)

0.50%

Change (1 year)

-41.45%

Change (YTD)

-33.53%

Teleflex Incorporated Share Price Year-To-Date (YTD) return on June 20, 2025: -33.53%

Teleflex Incorporated Share Price Year-To-Date (YTD) return is -33.53% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

Teleflex Incorporated 52-week low Share Price is USD 247.32 on June 20, 2025, which is 109.04% above the current Share Price.
Teleflex Incorporated 52-week low Share Price is USD 117.53 on June 20, 2025, which is -0.66% below the current Share Price.
Teleflex Incorporated average Share Price for the last 52 weeks is USD 184.44.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

NYSE: TFX

Teleflex Incorporated

CEO	Mr. Liam J. Kelly
IPO Date	March 17, 1980
Location	United States
Headquarters	550 East Swedesford Road
Employees	14,100
Sector	🏥 Health Care
Industries Medical Instruments 🔬 Clinical Trials 🏥 Hospitals & Clinics 💻 Telehealth

Description

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.